Upon hormone binding, a hydrophobic coactivator-binding groove is induced in the androgen receptor (AR) ligand-binding domain (LBD). This groove serves as high affinity docking site for α-helical
The androgen receptor (AR 1 ) is a key player in development and maintenance of male reproductive tissues (1, 2) . AR is a ligandinducible transcription factor of the nuclear receptor (NR) superfamily. Members of this family share a common structural and functional organization, including an N-terminal domain (NTD) harboring activation function 1 (AF-1), a central DNA-binding domain (DBD), and a Cterminal ligand-binding domain (LBD) containing activation function 2 (AF-2) (3) (4) (5) . Upon binding of its ligand, testosterone or 5α-dihydrotestosterone (DHT), AR LBD undergoes conformational changes leading to dissociation from heat-shock proteins and translocation to the nucleus (6) . At the DNA, AR binds to specific androgen response elements to initiate target gene expression. Cofactors facilitate AR transcription function by histone modifications, chromatin remodeling, and bridging of the receptor to other components of the transcription initiation process, including general transcription factors and RNA polymerase II (7) (8) (9) .
Although cofactors may functionally interact with all three NR domains, most extensive knowledge is available of LBD interaction. Crystal structures of NR LBDs have shown that ligand binding triggers repositioning of helix 12 (10) (11) (12) (13) . As a result a hydrophobic groove is formed, which serves as a docking site for amphipathic α-helical LxxLL motifs present in many cofactors. The specific affinity of LxxLL motifs for distinct NR LBDs depends on amino acid residues flanking the core L residues (10, (14) (15) (16) . Until now, only a limited number of LxxLL motifs have been reported to interact with the AR LBD (17) (18) (19) (20) . Instead, AR LBD prefers binding of FxxLF motifs, one of which is located in the AR NTD (17, 21, 22) . Although the function of the FxxLF motif-mediated interaction of AR NTD with AR LBD (N/Cinteraction) is not fully understood, it contributes to slowing of the androgen dissociation rate and selectively affects transcription of AR target genes (17, (22) (23) (24) (25) . Functional FxxLF motifs are also essential for interaction between AR LBD and cofactors ARA54, ARA70, and RAD9 (17, (26) (27) (28) . However, for the majority of AR binding proteins the mode of interaction remains to be elucidated (29) .
Alanine-scan mutagenesis of the AR FxxLF motif demonstrated that amino acid residues at positions +1, +4, and +5 are essential for interaction with the coactivator groove (21) . Modeling and crystal structures of AR LBD in complex with FxxLF-like peptides, including AR and ARA70 FxxLF motifs, showed that amino acid residues at positions +1 and +5 are buried in the coactivator groove, rendering these residues entirely solvent inaccessible (17, (30) (31) (32) . In contrast, the amino acid residue at position +4 rests in a shallow pocket on the periphery of the coactivator groove and is largely solvent exposed. Phage display screens for AR LBD interacting peptides and directed mutagenesis studies of the AR FxxLF motif demonstrated that not only F, but also M, Y, and W residues at positions +1 and +5 could be compatible with binding to the AR coactivator-binding groove, although F residues seem to be preferred (17, 18, 30) .
Although it is presumed that the requirements for the amino acid residue at +4 in the FxxLF motif are less stringent than those at +1 and +5, our actual knowledge in this respect is limited. Here we performed a systematic functional analysis of the AR FxxLF motif mutated at +4. Yeast two-hybrid and mammalian one-hybrid experiments demonstrated that L to F and L to M substitutions in the AR FxxLF motif are compatible with high affinity and specific AR LBD interaction. Strong and specific interaction was also obtained if the same substitutions were introduced in the ARA54 and ARA70 FxxLF motifs. As assessed by in vivo fluorescence resonance energy transfer (FRET) analysis, functional protein-protein interaction assays and mutagenesis, the AR partners gelsolin and PAK6 were found to contain an FxxFF and FxxMF motif, respectively, necessary and sufficient for AR LBD interaction.
EXPERIMENTAL PROCEDURES
Plasmids -Yeast and mammalian expression plasmids encoding Gal4AD-, Gal4DBD-, and YFP-peptide fusion proteins were generated by in-frame insertion of double-stranded synthetic oligonucleotides with 5'-BamHI and 3'-EcoRI cohesive ends into the corresponding sites of pACT2 (Takara Bio, Otsu, Shiga, Japan), pM-B/E (17), or in the BglII and EcoRI sites of pEYFP-C2 (Takara Bio), as described previously (17) . Mutagenesis of position +4 in the AR FxxLF motif was performed in oligonucleotides encoding AR [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Mutant oligonucleotides were inserted into pACT2 as described above. All peptide expression constructs were verified by sequence analysis.
Yeast expression construct pGalDBD-AR LBD (AR 661-919 ) has been described previously (33) . Constructs encoding Gal4DBD-fusions with LBDs of ERα, PR, and RXRα were generously provided by Michael Stallcup (34) . Mammalian constructs expressing wild type AR (pCMVAR 0 ) and F23L/F27L-AR (pCMVF23L/F27L-AR) have been described previously (17) . pM-PAK6 12-681 was generated by subcloning a BglII-XbaI fragment from pSPORT6-PAK6 (IRAKp961I1968Q; RZPD, Berlin, Germany) into the BamHI and XbaI sites of pM (Takara Bio). pM-Gelsolin was obtained by subcloning an EcoRI-digested PCR fragment encoding amino acid residues 281-731 of gelsolin into pM. PCR was performed using primers 5'-GATCGAATTCTTCATCCTGGACCACG-3' and 5'-GATCGAATTCCTCAGGCAGCCAGCTC-3' (EcoRI sites in bold) on pOTB7-Gelsolin (IMAGp958I211459Q; RZPD). (37) . For one-hybrid assays, cells were transfected with 50 ng Gal4DBD-peptide or Gal4DBD-protein expression construct, 50 ng AR expression construct, and 150 ng (UAS)4TATA-LUC construct, in the presence of 100 nM DHT or vehicle. Luciferase activity was determined as described previously (17, 37) .
For FRET experiments, Hep3B cells were cultured overnight on glass cover slips in 9.5 cm 2 wells in α-minimal essential medium (α-MEM) supplemented with 5% FCS, L-glutamine and antibiotics. Four h prior to transfection the medium was substituted by 1 ml α-MEM containing 5% charcoal-stripped FCS. Cells were transfected with 1 µg pCYFP, or 1 µg pCFP-ARLBD and 0.5 µg YFP-peptide expression construct, together with 3 µl Fugene 6 (Roche Diagnostics, Mannheim, Germany) per µg DNA in 100 µl α-MEM. Four h after transfection the medium was substituted by 2 ml α-MEM containing 100 nM DHT. FRET assays were done the next day. Western blot analysis -Yeast protein extraction and Western blot analysis for detection of Gal4AD fusion proteins were performed as described previously (21, 33) . Proteins were visualized using a monoclonal antibody against Gal4AD (Takara Bio). FRET measurement by acceptor photobleaching -Live cell imaging was performed using a Zeiss LSM510 confocal laser scanning microscope equipped with a Plan-Neofluar 40x/1.3 NA oil objective (Carl Zeiss, Jena, Germany) at a lateral resolution of 100 nm. CFP and YFP images were collected sequentially at 458 nm and 514 nm excitation, respectively, using a 458/514 nm dichroic beam splitter, a 515 nm beam splitter, and specific emission filters. CFP was excited with the 458 nm laser line of an Argon laser at moderate laser power and detected using a 470-500 nm band pass emission filter. YFP excitation was at 514 nm at moderate laser power and detected using a 560 nm emission filter. After sequential collection of YFP and CFP images, YFP was bleached by scanning 25 times a nuclear region of ~100 µm 2 , covering a large part of the nucleus, using the 514 nm argon laser line at high laser power. After acceptor photobleaching a second YFP and CFP image pair was collected. The apparent FRET efficiency was calculated after background subtraction as: 
RESULTS

L to F and L to M substituted AR FxxLF motifs strongly interact with AR LBD -
Although the importance of the core hydrophobic amino acid residues at positions +1 and +5 in FxxLF motifs has been described (17, 21, 26) , little is known about the amino acid requirements at +4 for AR LBD binding. To study this, we tested every amino acid at this position in the context of the AR FxxLF motif using a yeast two-hybrid readout system (Fig. 1A) . In this assay, peptides were expressed as fusions to Gal4AD and AR LBD was fused to Gal4DBD. All assays were done in the presence of DHT (17) . Western blot analysis of transformed yeast cells demonstrated that all Gal4AD-peptide fusion proteins were appropriately expressed (Fig. 1B) . The yeast two-hybrid screening showed that most L+4 substitutions completely abolished AR LBD interaction (Fig. 1B) . Reduced interaction was observed with peptides containing a W, T, I, V, C, or Y residue at position +4 instead of an L. In contrast, AR LBD interactions were identical or even stronger than wild type motif if L+4 was substituted by F or M. FxxFF and FxxMF variants of AR, ARA54, and ARA70 FxxLF motifs interact with AR LBD in mammalian cells -Next, we evaluated interaction capacities of FxxFF and FxxMF variants of AR FxxLF with full-length wild type AR in a mammalian one-hybrid assay ( Fig. 2A and (17) Effects of F and M residues at position +4 on AR specificity -Previously, we and others have demonstrated that FxxLF motifs, including those of AR and ARA54, display high specificity for AR ((17,26,38) and Dubbink, unpublished results). However, some FxxLF motifs, including the ARA70 motif, also interacted with PR (Dubbink, unpublished results). We studied in yeast two-hybrid experiments the effect of L to F and L to M substitutions at position +4 in the AR, ARA54, and ARA70 FxxLF motifs on AR specificity. Peptides were fused to Gal4AD and LBDs of ERα, PR, and RXRα were fused to Gal4DBD. Upon ligand binding all NR LBDs adopted a functional conformation since strong interaction with a control LxxLL peptide D11 was observed ((39) and data not shown). Contrary to a potent interaction with AR LBD (Fig. 3A) , none of the FxxFF and FxxMF variant motifs interacted with LBDs of ERα, PR, or RXRα (Fig. 3B and data not shown) . The specificity of the ARA70 FxxLF motif even increased upon L to F and L to M substitutions as no PR LBD interaction was observed with the variant ARA70 motifs (Fig. 3B) . The weak β-galactosidase activities detected with PR LBD were due to the intrinsic activity of Gal4DBD-PR LBD since similar values were obtained when this construct was expressed in the absence of a peptide expression construct (data not shown). These results demonstrate that L to F and L to M substitution variants of FxxLF motifs remain AR specific or become even more specific.
Naturally occurring AR-interacting FxxFF and FxxMF motifs -To assess a role of FxxFF and
FxxMF motifs in cofactor-AR LBD interaction, we screened all AR interacting proteins present in the AR gene mutations database (www.mcgill.ca/androgendb; (29) ) and in the human protein reference database (www.hprd.org) for the presence of these motifs. This yielded two proteins with an FxxFF (gelsolin and cdc37) and two with an FxxMF motif (PAK6 and supervillin). Mammalian onehybrid experiments showed that the cdc37 FxxFF and supervillin FxxMF motifs weakly interacted with F23L/F27L-AR, but not with wild type AR (data not shown). In contrast, the gelsolin FxxFF and PAK6 FxxMF motifs displayed strong hormone-dependent interactions with both F23L/F27L-AR and wildtype AR (Figs 4A and B) . AR N/C-interaction did not affect gelsolin FxxFF binding to AR LBD, but reduced binding of the AR FxxLF and PAK6 FxxMF motifs, indicating that the gelsolin FxxFF motif had a higher affinity for AR LBD than the AR FxxLF and PAK6 FxxMF motifs. Both motifs are predicted to adopt an amphipathic α-helical structure (Figs 4C and D) . FxxFF and FxxMF motifs present in AR cofactors gelsolin and PAK6 may thus be essential for interaction with AR.
To extend our knowledge on the interactions between AR LBD and gelsolin FxxFF and PAK6 FxxMF peptide motifs, in vivo FRET experiments were carried out (Fig. 5A ).
Hep3B cells were transiently co-transfected with constructs expressing CFP-tagged AR LBD and YFP-tagged peptide motifs. Close association of ligand-bound CFP-tagged AR LBD and YFPtagged peptide results in energy transfer (FRET) by excitated CFP donor to YFP acceptor ( Fig.  5A; left) (40) . FRET efficiency was estimated by acceptor photobleaching (Figs 5A middle and right) (41, 42) . FRET intensity was calculated based on the difference in CFP emission intensities before and after YFP photo destruction as described in Experimental Procedures.
FRET signals between AR LBD and FxxLF motifs of AR, ARA54, and ARA70 were readily detected in the presence of ligand (Fig.  5B) . FRET signals between AR LBD and either gelsolin FxxFF or PAK6 FxxMF motifs were similar (Fig. 5C ). These findings demonstrate direct in vivo interactions of AR LBD with gelsolin FxxFF and PAK6 FxxMF peptides. Alanine scanning and AR LBD specificity of gelsolin FxxFF and PAK6 FxxMF motifs -To further characterize the gelsolin FxxFF and PAK6 FxxMF motifs we performed an alaninescan by substituting consecutive doublet residues in both motifs into alanine residues (Fig. 6A) . Mammalian one-hybrid results show that alanine substitutions encompassing the core hydrophobic residues at positions +1, +4, and +5 of both gelsolin and PAK6 completely abrogated AR interactions (Figs 6B and C). Residues at positions +6 and +7 of the PAK6 motif, but not of the gelsolin FxxFF motif, also appeared important for AR LBD interaction. All other alanine substitutions hardly interfered with AR binding.
As found for AR, ARA54, and ARA70 peptide motifs, gelsolin FxxFF and PAK6 FxxMF strongly bound to AR LBD, but hardly or not to the LBDs of ERα, PR, and RXRα (Fig.  7) .
AR LBD binding of cofactors gelsolin and PAK6
is FxxFF and FxxMF-mediated -Next, we investigated the importance of the FxxFF and FxxMF motifs for interaction of gelsolin and PAK6 with AR. PAK6 (aa 12-681) and gelsolin (aa 281-731) were fused to Gal4DBD and allowed to interact with AR in the mammalian read-out system. As expected, both proteins interacted with wild type AR (Fig. 8A) and binding was increased if the competing FxxLF motif in AR NTD was inactivated (Fig. 8B) . However, if the FxxFF motif in gelsolin and the FxxMF motif in PAK6 were mutated into FxxAA, interactions with both wild type AR and F23L/F27L-AR were abolished. Gelsolin and PAK6 protein expression levels were not affected by the mutations (data not shown). These data clearly demonstrate that the FxxFF and FxxMF motifs in gelsolin and PAK6, respectively, are necessary and sufficient for AR interaction.
DISCUSSION
Upon agonist binding the architecture of the AR LBD surface is rearranged to allow high affinity binding of FxxLF motifs present in AR NTD and in AR cofactors. Binding of these short amphipathic α-helical structures turned out to depend strongly on optimal docking of the F residues at +1 and +5 in the coactivator-binding groove of AR LBD (17, 21) . Although the coactivator groove is sufficiently flexible to accommodate other large hydrophobic amino acid residues, F residues at +1 and +5 are preferred (17, 18, 30) . Based on functional assays we here provide insight in the requirements of the amino acid at position +4 of peptide motifs for optimal AR LBD binding. We demonstrate that L+4 can be substituted by F and M residues in the AR, ARA54, and ARA70 FxxLF motifs, retaining strong and selective AR binding. Novel AR-interacting FxxFF and FxxMF motifs were identified in AR cofactors gelsolin and PAK6, respectively.
Systematic mutation screening of position +4 of the AR FxxLF motif resulted in the identification of three categories of peptides (Fig. 1) . (1) The largest group of peptides does not interact with AR LBD. This group includes small hydrophobic, charged, or polar residues at +4; (2) Several peptides showed reduced interaction with AR LBD (C, I, T, V, W, and Y). Most of these variants have a hydrophobic residue at +4; and (3) strongly interacting variants containing bulky hydrophobic side chains (L, F, and M). Strong binding by L, F, and M residues indicates that hydrophobic contacts underlie the ability to interact with AR LBD. The inability or limited potency of most +4 variants to bind AR LBD can be due to destabilization of the peptide by distortion of the helical structure, active interference with LBD interaction caused by the charge or size of the side chains or the incapability to form sufficient hydrophobic contacts with the AR LBD. Our findings underscore the importance of the amino acid residue at +4 for optimal binding of peptide motifs to AR LBD, even though this amino acid residue is not deeply buried in the binding pocket (30, 31) .
Phage display screens of random peptide libraries with full length AR or AR LBD as bait yielded different AR-interacting motifs containing F residues at positions +1 and +5 (30, 38) . Besides the classical FxxLF sequences, FxxVF, FxxYF, and FxxFF motifs were identified in these screens. The FxxVFcontaining peptide weakly interacted with AR, as is in agreement with our screening results, and strong interactions were observed with FxxYF and FxxFF sequences (38) . In our +4 mutation screen of AR FxxLF, the FxxYF variant showed decreased interaction with AR LBD, suggesting that in this specific FxxYF motif the Y residue has a less optimal position for AR LBD binding. Similar data were found for ARA54 and ARA70 FxxLF-based FxxYF variants (data not shown). So, the requirement for the amino acid at +4 might depend on the further context of the motif. Chang and co-workers (38) demonstrated that most FxxYF and FxxFF peptide motifs picked up in phage display screens interacted with AR LBD not only in the presence but also in the absence of ligand. Repetition of these experiments in our interaction assay indicated that ligand was essential for AR LBD interaction (data not shown). This apparent discrepancy might be due to differences in read-out systems.
Recently, crystal structures of AR LBDs in complex with the AR FxxLF and ARA70 FxxLF motifs and FxxLF, FxxFF, and FxxYF peptides selected by phage display have been resolved (30) (31) (32) . Comparing LBDs with and without bound peptide showed that the side chains of amino acid residues in AR LBD that line the coactivator groove rearrange upon binding of the peptide motif. Largest conformational changes were observed for K720, M734, M894, and E897, leading to optimal binding sites for residues +1, +4, and +5 of interacting peptide motifs (30) (31) (32) . The Fs at positions +1 and +5 are buried in a deep solvent inaccessible groove in AR LBD. This mode of interaction is largely conserved suggesting that these residues drive the interaction of the peptide motif (30) . In contrast, the binding mode of the residue at position +4 seems less critical. This residue binds to a shallow hydrophobic depression formed by L712, V713, V716, and M894 in AR LBD (Fig. 9) (30-32) . Based on the crystal structures, the side chains of the different amino acids at +4 studied so far (L, F, and Y) form hydrophobic contacts with V713, V716, and M894 in the groove with an additional contact formed between the FxxYF peptide and K717 of AR LBD. As shown in Figure 9 , the FxxFF peptide has shifted in the coactivator groove towards the K720 residue as compared to the FxxLF and FxxYF peptide motifs (30) . This shift together with a less optimal helical geometry of the peptide backbone makes that the F at +4 has a different orientation than an L or Y at this position (30) . We have shown in this study that +4 of the peptide motif can also be an M. Because of the variability of the position of the +4 residue in the complex with AR LBD and because M has a highly flexible side chain, its precise positioning in the coactivator groove cannot be accurately predicted.
In contrast to LxxLL motifs, FxxLF motifs show a strong preference for AR (17, 26) . Some FxxLF motifs, including the ARA70 FxxLF motif, also interact with PR ( (38) and unpublished results). The FxxFF and FxxMF motifs tested in the present study also specifically interacted with AR. L to F and L to M substitutions increased specificity of the ARA70 FxxLF motif. We hypothesize that M and F residues at position +4 select against binding to the coactivator-binding groove of PR. In agreement with this hypothesis, ARinteracting FxxLF and FxxFF peptides selected by phage display show a similar selectivity for AR: only 1 out of 5 FxxFF peptides interacted with PR LBD as compared to 4 out of 6 FxxLFpeptides (38) . Of the residues in the AR coactivator-binding groove that contact the +4 side chains in FxxLF and FxxFF peptides (see Fig. 9 ) only V713 differs from the corresponding L727 residue in PR. As recently shown by He et al., V713L substitution in AR LBD reduced binding of the AR FxxLF motif. Vice versa, L727V substitution in PR LBD increased binding of the AR FxxLF motif (31) . We presume that the size and orientation of L727 in PR LBD precludes binding of peptide motifs with bulky F and M residues at position +4.
Although the mode of interaction of the majority of cofactors with AR LBD is unknown, for several, including ARA54, ARA70, and RAD9, an essential FxxLF motif has been established (17, (26) (27) (28) . Here we demonstrated that two other AR interacting proteins, gelsolin and PAK6, interact with AR LBD via an FxxFF and FxxMF motif, respectively. Gelsolin is an actin capping and severing protein, and is presumed to act as an AR cofactor by facilitating nuclear translocation (43) . Interestingly, also other members of the gelsolin family, including flightless-1 and supervillin, have been identified as cofactors of AR and other NRs, suggesting an important role in NR function (44,45). The gelsolin FxxFF motif is not only highly conserved among different species, but also among different members of the gelsolin family. Our preliminary data revealed that the conserved FxxFF motif present in adseverin also strongly binds AR LBD, suggesting that adseverin may act as an AR cofactor as well (data not shown). PAK6 is a member of the PAK family of serine/threonine kinases, which is, based on homology, divided into two subfamilies (Group I: PAK1, PAK2, and PAK3; Group II: PAK4, PAK5, and PAK6) (46). Although the FxxMF motif in PAK6 is conserved in other species, it is not conserved in any of the other members of the PAK family and so far PAK6 is the only member known to modulate NR function. PAK6 might repress AR function by phosphorylation of the DBD (47). Hormone-dependent interactions with AR LBD were observed in yeast two-hybrid and co-immunoprecipitation experiments, whereas GST pull-down experiments indicated that these LBD interactions were hormone-independent and also involved the hinge region (48,49). Our results unambiguously demonstrated that the novel FxxMF motif is sufficient and necessary for hormone-dependent interaction of PAK6 with AR LBD.
The identification of the FxxFF and FxxMF motifs in AR cofactors raises the possibility that other so far unrecognized proteins interact with AR LBD via similar motifs. Based on these findings, it would be of interest to perform a proteome-wide in silico screen for Fxx(L/F/M)F peptide motifs combined with functional protein-protein interaction assays to identify new candidate AR partners.
Prostate cancer growth is dependent on the androgen-AR axis (50,51). Nonetheless, endocrine treatment of metastatic prostate cancer by androgen withdrawal or blocking AR activity by antagonists is not curative, even though AR is still active in progressive disease in most cases (52). AR N/C-interaction and cofactor interactions are important steps in AR activation. Disruption of these interactions might be a complementary or alternative approach to more efficiently inhibit AR function. Increased knowledge of the mode of AR LBD-peptide interaction will be instrumental in the design of small molecules that fit in the AR coactivatorbinding groove and block protein interactions. 
